Gunnar Telhammar
Direttore Finanziario/CFO presso XINTELA AB
Posizioni attive di Gunnar Telhammar
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| XINTELA AB | Direttore Finanziario/CFO | 01/01/2013 | - |
| ACOUSORT AB | Direttore Finanziario/CFO | 01/01/2016 | - |
| LIFEASSAYS AB (PUBL) | Direttore Finanziario/CFO | - | - |
| TENDO AB | Direttore Finanziario/CFO | - | - |
| SENSODETECT AKTIEBOLAG | Direttore Finanziario/CFO | - | - |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Direttore Finanziario/CFO | - | - |
| BioFinans AB | Direttore/Membro del Consiglio | 01/01/2004 | - |
| Amministratore Delegato | 01/01/2004 | - | |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Direttore Finanziario/CFO | 01/01/2019 | - |
| Direttore/Membro del Consiglio | 01/01/2019 | - |
Storia della carriera di Gunnar Telhammar
Precedenti posizioni note di Gunnar Telhammar
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Telepartner AS (Norway) | Direttore Finanziario/CFO | 01/01/1990 | 01/01/1996 |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Gunnar Telhammar
| University of Lund | Graduate Degree |
Statistiche
Distribuzione geografica
| Svezia | 14 |
| Norvegia | 2 |
Posizioni
| Director of Finance/CFO | 11 |
| Director/Board Member | 2 |
| Comptroller/Controller/Auditor | 1 |
Settori
| Health Technology | 9 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 7 |
|---|---|
| SENSODETECT AKTIEBOLAG | Commercial Services |
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| ACOUSORT AB | Distribution Services |
| XINTELA AB | Health Technology |
| BIBBINSTRUMENTS AB | Health Technology |
| AEGIRBIO AB | Health Technology |
| TENDO AB | Health Technology |
| Aziende private | 6 |
|---|---|
LifeAssays AB
 LifeAssays AB Medical SpecialtiesHealth Technology LifeAssays AB is a diagnostic company, which engages in the provision of point-of-care diagnostic testing for veterinarians, community health centers and primary physicians. It's products include own produced instruments and disposable agents as well as blood analysis systems LifeAssays Reader and LifeAssays VetReader. The company was founded on August 17, 2000 and is headquartered in Lund, Sweden. | Health Technology |
| Preelumina Diagnostics AB | |
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Health Technology |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Health Technology |
| BioFinans AB | |
| Telepartner AS (Norway) |
- Borsa valori
- Insiders
- Gunnar Telhammar
- Esperienza
